Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis.

MLA

Stober, Carmel, et al. “Prevalence and Predictors of Tumour Necrosis Factor Inhibitor Persistence in Psoriatic Arthritis.” Rheumatology (Oxford, England), vol. 57, no. 1, Jan. 2018, pp. 158–63. EBSCOhost, https://doi.org/10.1093/rheumatology/kex387.

APA

Stober, C., Ye, W., Guruparan, T., Htut, E., Clunie, G., & Jadon, D. (2018). Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis. Rheumatology (Oxford, England), 57(1), 158–163. https://doi.org/10.1093/rheumatology/kex387

Chicago

Stober, Carmel, Weiyu Ye, Thushyanthan Guruparan, Eiphyu Htut, Gavin Clunie, and Deepak Jadon. 2018. “Prevalence and Predictors of Tumour Necrosis Factor Inhibitor Persistence in Psoriatic Arthritis.” Rheumatology (Oxford, England) 57 (1): 158–63. doi:10.1093/rheumatology/kex387.